Part 4: atracurium besylate
and related polyalkylene diesters.
Intubation with non-depolarising muscle relaxants like vecuronium bromide and atracurium besylate
where Suxamethonium is contraindicated needs a larger dose and period of waiting for more than 3 minutes.
Anaesthesia was continued with isoflurane 0.8 - 1% and nitrous oxide 70% in oxygen 30% controlled ventilation was facilitated by atracurium besylate
. At the end of the operation, the stay suture and adhesive tape were removed and tracheal tube was pulled back to the oral cavity followed by pilot balloon.
Eventually it was presented as a besylate salt and produced for clinical testing as atracurium besylate
, an aqueous solution of 10 mg/ml.
* Induction with Injection Propofol 2mg/kg i/v, Injection Tramadol 1mg/kg i/v and Injection Atracurium Besylate
0.5mg/kg i/v to facilitate tracheal intubation.
M2 EQUITYBITES-May 21, 2012-Sagent Pharmaceuticals Inc unveils skeletal muscle relaxant drug Atracurium Besylate
Injection(C)2012 M2 COMMUNICATIONS http://www.m2.com
M2 PHARMA-May 21, 2012-Sagent Pharmaceuticals Inc unveils skeletal muscle relaxant drug Atracurium Besylate
Injection(C)2012 M2 COMMUNICATIONS
Clinical pharmacology of atracurium besylate
(BW33A): A new non-depolarising muscle relaxant.
given intravenously and repeat dose of 5 mg atracurium given each time by observing TOF response more or equal to 2 out of 4.
Tenders are invited for Injection Atracurium Besylate